Impact of antibiotic guideline compliance on duration of mechanical ventilation in critically ill patients with community-acquired pneumonia

Chest

Volumn 130, Issue 1, 2006, Pages 93-100

  Shorr, Andrew F ^a   Bodi, Maria ^b   Rodriguez, Alejandro ^b   Sole Violan, Jorge ^c   Garnacho Montero, Jose ^d   Rello, Jordi ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Antibiotics; Community acquired pneumonia; Guidelines; Mechanical ventilation; Outcomes

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALCOHOL CONSUMPTION; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CANCER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CRITICALLY ILL PATIENT; DEMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; FEMALE; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HEART DISEASE; HUMAN; INTRAVENOUS DRUG ABUSE; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MYCOBACTERIUM TUBERCULOSIS; NEUROLOGIC DISEASE; OBESITY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REGISTER; RETROSPECTIVE STUDY; SMOKING; SPAIN; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 33746339224     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.1.93     Document Type: Article

References (23)

1. Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37:1405-1433
2. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754
3. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250
4. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377-382
5. Rello J, Diaz E. Pneumonia in the intensive care unit. Crit Care Med 2003; 31:2544-2551
6. Angus DC, Marrie TJ, Obrosky DS, et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med 2002; 166:717-723
7. Kaplan V, Angus DC, Griffin MF, et al. Hospitalized community-acquired pneumonia in the elderly, age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002; 165:766-772
8. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278:2080-2084
9. Fine JM, Fine MJ, Galusha D, et al. Patient and hospital characteristics associated with recommended processes of care for elderly patients hospitalized with pneumonia: results from the Medicare quality indicator system pneumonia module. Arch Intern Med 2002; 162:827-833
10. Trivedi AN, Zaslavsky AM, Schneider EC, et al. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med 2005; 353:692-700
11. Williams SC, Schmaltz SP, Morton DJ, et al. Quality of care in U.S. hospitals as reflected by standardized measures, 2002-2004. N Engl J Med 2005; 353:255-264
12. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med 2002; 162:682-688
13. Bodí M, Rodríguez A, Solé-Violán J, et al. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to IDSA guidelines on outcome. Clin Infect Dis 2005; 41:1709-1716
14. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
15. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829
16. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244
17. Menendez R, Torres A, Zalacain R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004; 59:960-965
18. Micek ST, Isakow W, Shannon W, et al. Predictors of hospital mortality for patients with severe sepsis treated with drotrecogin alfa (activated). Pharmacotherapy 2005; 25:26-34
19. Kollef M. Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. Drugs 2003; 63:2157-2168
20. Mortensen EM, Restrepo M, Anzueto A, et al. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med 2004; 117:726-731
21. Ewig S, de Roux A, Bauer T, et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004; 59:421-427
22. Ely EW, Baker AM, Dunagan DP, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996; 335:1864-1869
23. Kress JP, Pohlman AS, O'Connor MF, et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342:1471-1477